Brief: Bajaj Healthcare's API Manufacturing Site At Vadodara Gets Approval From TGA Australia
06/12/2024 12:49
Dec 6 (Reuters) - Bajaj Healthcare Ltd BAJH.NS :
* APPROVAL FROM THERAPEUTIC GOODS ADMINISTRATION (TGA),
AUSTRALIA
* CO'S API MANUFACTURING SITE AT VADODARA GETS APPROVAL FROM
TGA
AUSTRALIA
* VADODARA SITE HAS ALREADY RECEIVED APPROVAL FROM USFDA AND
EU
* TGA APPROVAL VALID FOR 24 MONTHS
Source text: ID:nBSE374MtW
Further company coverage: BAJH.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Bajaj Healthcare
See all newsIndia's Bajaj Healthcare falls on agreement to sell Gujarat undertaking for $1.5 million
Brief: Bajaj Healthcare June-Quarter Profit 137 Million Rupees
Brief: Bajaj Healthcare's Board Approves Sale Of Operational Business Unit At Tarapur
Brief: Bajaj Healthcare Ltd Posts March-Quarter Loss 228.5 Million Rupees
Brief: Bajaj Healthcare Posts Dec-Quarter Profit Of 156.7 Million Rupees